Purity of ruthenium red used in pharmacological research

Fletcher, 1961, Ruthenium red, J Chem Soc, 2000, 10.1039/jr9610002000 Gupta, 1988, Responses of contractile function to ruthenium red in rat heart, Am J Physiol, 255, H1413 Luft, 1971, Ruthenium red and violet. I. Chemistry, purification, methods of use for electron microscopy and mechanism of action, Anat Rec, 171, 347, 10.1002/ar.1091710302 1983, 1195 Moore, 1971, Specific inhibition of mitochondrial Ca++ transport by ruthenium red, Biochem Biophys Res Commun, 42, 298, 10.1016/0006-291X(71)90102-1 Park, 1990, Protection against hypoxic injury in isolated-perfused rat heart by ruthenium red, J Pharmacol Exptl Therap, 253, 628 Peng, 1980, Improvement of mitochondrial energy production in ischemic myocardium by in vivo infusion of ruthenium red, J Cardiovasc Pharmacol, 2, 45, 10.1097/00005344-198001000-00006 Reed, 1974, The inhibition of mitochondrial calcium transport by lanthanides and ruthenium red, Biochem J, 140, 143, 10.1042/bj1400143 Smith, 1980, Depressed contractile function in reperfused canine myocardium: metabolism and response to pharmacological agents, Cardiovasc Res, 14, 458, 10.1093/cvr/14.8.458 Sordahl, 1977, Functions of selected biochemical systems from the exercised-trained dog heart, J Appl Physiol, 42, 426, 10.1152/jappl.1977.42.3.426 Thomas, 1988, Effect of extracellular Ca++ omission on isolated hepatocytes. II. Loss of mitochondrial membrane potential and protection by inhibitors of uniport Ca++ transduction, J Pharmacol Exptl Therap, 245, 501 Vasington, 1972, The effect of ruthenium red on Ca2+ transport and respiration in rat liver mitochondria, Biochim Biophys Acta, 256, 43, 10.1016/0005-2728(72)90161-2